IDSA to take another look at long-term use of antibiotics for Lyme disease
In a settlement with the Connecticut attorney general, the Infectious Diseases Society of America agreed to evaluate its Lyme disease guidelines and use of antibiotics.
The Infectious Diseases Society of America has agreed to a settlement, bringing to a close an investigation by the Connecticut Attorney General over possible antitrust violations. At issue is IDSA’s position against prolonged use of antibiotics to treat Lyme disease. In the settlement agreement, IDSA denied any wrongdoing, but agreed to review its clinical guidelines and name an ombudsman to evaluate its review panel for conflicts of interest.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025
March 31st 2025Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.
